Menu

Missing Brains Found

About 100 human brains belonging to a university collection thought lost have turned up at another campus. 

Dec 3, 2014
Kerry Grens

WIKIMEDIA, DRDAKDozens of human brains stored in a basement at the University of Texas (UT) at Austin had been missing for years. But recent media attention on the absent jars has helped resolve their whereabouts: UT San Antonio.

“They read a media report of the missing brains and they called to say: ‘We got those brains!’” Tim Schallert, the former curator of the Austin collection, told the Los Angeles Times.

The organs represent roughly half of a brain collection that had arrived at UT Austin a few decades ago from the Austin State Hospital. According to an excerpt from the book Malformed: Forgotten Brains of the Texas State Mental Hospital published in The Atlantic this week (December 2), the brains got shuffled around because the center where they were housed at UT Austin became too crowded. But in the mid-1990s, when Schallert went to move them, the jars were nowhere to be found. “I never found out exactly what happened—whether they were just given away, sold or whatever—but they just disappeared,” Schallert said in the book.

Fortunately, the mystery is solved. “I know the brains will be treated very well there,” Schallert told the Times.

UPDATE (December 5): Following an investigation by the University of Texas, it turns out that the brains had not gone to UT San Antonio, but in fact had been destroyed in 2002, the Associated Press reported.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.